With its in-depth understanding of human stem cells and its proprietary technology of haploid human embryonic stem cells, NewStem intends to change the paradigm of life sciences and the way we develop therapeutics and diagnostics.
Our Technology
NewStem provides new groundwork for numerous biomedical applications in advanced cancer research. With the combined advantages of haploid genetics and pluripotency, Haploid human ESCs now pave the way for numerous new biomedical applications. Our HhESCs exhibited typical pluripotent stem cell characteristics, such as self-renewal capacity and a pluripotency specific molecular signature, meaning they are able to differentiate into many other cell types, including nerve, heart, and pancreatic cells, while retaining a single set of chromosomes.
Our Technology at a Glance
Publications
Partnership Opportunities
NewStem prioritizes selective collaborations with strategic companies and promising start-ups, aimed at leveraging NewStem’s proprietary technology of haploid human embryonic stem cells (HhESC) and our in-depth understanding of human stem cells for the development of advanced and novel solutions for unmet medical needs.